Naloxone

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Naloxone and local guidelines before prescribing.

Opioid antagonist

Mechanism

Competitive opioid receptor antagonist.

Uses

Opioid overdose reversal, postoperative respiratory depression.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Opioid toxicity0.04–0.4 mg IV titratedReverse breathing, not full consciousness.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

4 more dose entries from the chapters

Side effects

Withdrawal in dependent patients (agitation, vomiting, pulmonary oedema), short duration.

Interactions

Reverses opioid analgesia.

Contraindications and cautions

Opioid dependence (withdrawal)

Monitoring

Respiratory rate, consciousness

Pregnancy and breastfeeding

Acceptable

Renal and hepatic impairment

No adjustment

Overdose and reversal

Not applicable

Special advice

Short half-life, so re-sedation may occur; observe and repeat or infuse; titrate in postoperative use.

More from the textbook: uses, cautions and other points
Where it is discussed in the book